Plain-English translation of NCT05606068 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a novel device called a limb cryocompression system—essentially cooling wraps that are wrapped around your arms and legs—to see if it can prevent chemotherapy-induced peripheral neuropathy, a common side effect where patients experience numbness, tingling, or pain in their extremities. The study will enroll 200 cancer patients receiving weekly paclitaxel chemotherapy (with or without other chemotherapy drugs) and apply the cooling wraps during their treatment cycles to determine whether this treatment is safe and effective when used repeatedly.
Many cancer patients experience nerve damage as a side effect of chemotherapy, which can cause persistent pain and numbness in the hands and feet. This trial is exploring whether cooling the limbs during chemotherapy can prevent or reduce this nerve damage, offering patients a way to protect themselves from this difficult long-term side effect.
You likely qualify if…
You likely don't qualify if…
You would receive cooling wraps applied to your limbs (from your fingers or toes up to your elbows or knees) during each cycle of your weekly chemotherapy treatment. The wraps use a cooling device set to a specific temperature and pressure that was determined to be safe and effective in earlier studies. You would undergo this cooling treatment repeatedly across multiple chemotherapy cycles so researchers can monitor whether it is tolerated well and whether it helps prevent the nerve damage that chemotherapy can cause.
AI-generated summary from trial data · Jun 25, 2026 · Not medical advice
Singapore